KRBP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 15:36):

Stats
Today's Volume	602.00
Average Volume	3 484.00
Market Cap	4.94M
EPS	$0 ( 2024-05-13 )
Next earnings date	( $0 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-14	Ralston Shannon	Buy	2 783 140	Series C Convertible Voting Preferred Stock
2024-05-14	Ralston Shannon	Buy	3 438 904	Series D Convertible Voting Preferred Stock
2023-07-25	Ralston Shannon	Buy	444 045	$2,400,000 Senior Secured Convertible Note
2023-09-27	Ralston Shannon	Buy	556 333	$2,400,000 Senior Secured Convertible Note
2023-11-02	Ralston Shannon	Buy	1 089 333	$2,400,000 Senior Secured Convertible Note

INSIDER POWER
88.93
Last 55 transactions
Buy: 2 104 003 \| Sell: 1 153 594

Kiromic BioPharma, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations
QLYS	-0.842
CMAX	-0.812
PGC	-0.81
UBFO	-0.805
SSBI	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kiromic BioPharma, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-19.09

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-19.09

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-70.12

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-5.68

Financial Reports:

No articles found.

Kiromic BioPharma, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Kiromic BioPharma, Inc.

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.